I have it around 17c. That means the company is currently trading at around a $30mill enterprise value.
On my numbers, that would equate with earnings expected from just a 0.1% share of the market.
I have a sp target of $3.50 for a 1% share of the global market, or $7 if they can get a 2% share of the market.
Assumptions are a 90% margin, 15% of gross profit spent on R&D and other overheads, a 30% tax and a PE of 15.
Those numbers are academic as my actual expectation is some sort of corporate activity before FDA approval.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.010(2.82%) |
Mkt cap ! $38.62M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 34.5¢ | $179.4K | 508.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 65456 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 27806 | 2 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| LTP (ASX) Chart |